Differential expression and response to anti-TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis
Corresponding Author
Leen De Rycke
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Department of Rheumatology, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.Search for more papers by this authorDominique Baeten
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorDirk Foell
Department of Pediatrics, University of Münster, Münster, Germany
Search for more papers by this authorElli Kruithof
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorEric M Veys
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorJohannes Roth
Institute of Experimental Dermatology, University of Münster, Münster, Germany
Search for more papers by this authorFilip De Keyser
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorCorresponding Author
Leen De Rycke
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Department of Rheumatology, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.Search for more papers by this authorDominique Baeten
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorDirk Foell
Department of Pediatrics, University of Münster, Münster, Germany
Search for more papers by this authorElli Kruithof
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorEric M Veys
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorJohannes Roth
Institute of Experimental Dermatology, University of Münster, Münster, Germany
Search for more papers by this authorFilip De Keyser
Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
Search for more papers by this authorAbstract
Synovial macrophages play a pivotal role in the pathogenesis of chronic autoimmune arthritis by contributing to local inflammation and tissue damage and are therefore a primary target for therapeutic intervention. The aim of the present study was to investigate in more detail the relative contribution of different synovial macrophage subsets with potentially different inflammatory or anti-inflammatory functions by analysing the two most frequent forms of human autoimmune arthritis, spondyloarthropathy (SpA) and rheumatoid arthritis (RA). Both infiltrating macrophages from peripheral blood expressing myeloid-related proteins (MRP) 8 and 14, and resident tissue macrophages expressing CD163 were abundant in inflamed synovium. Whereas the global number of synovial macrophages was similar in both diseases, infiltrating macrophages were increased in the RA lining layer in contrast with resident tissue macrophages, which were more frequently observed in SpA. Soluble MRP8/MRP14 complexes, which were secreted locally in the joint during the infiltration process, were increased in the serum of arthritis patients and, in contrast with soluble CD163 shed from resident tissue macrophages, correlated well with global inflammatory parameters. Treatment in vivo with anti-TNFα had a rapid and pronounced effect on the infiltration of MRP-positive macrophages into tissues, as evidenced by histopathological analysis and serum MRP8/MRP14 levels. Taken together, these data support an important role for infiltrating versus resident tissue macrophages in human autoimmune synovitis and indicate that macrophage products such as soluble MRP8/MRP14 complexes are valuable biomarkers for the experimental and clinical monitoring of specific disease mechanisms in vivo. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
References
- 1Sack U, Stiehl P, Geiler G. Distribution of macrophages in rheumatoid synovial membrane and its association with basic activity. Rheumatol Int 1994; 13: 181–186.
- 2Tak PP, Smeets TJM, Daha MR, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997; 40: 217–225.
- 3Kraan MC, Versendaal H, Jonker M, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998; 41: 1481–1488.
- 4Baeten D, Demetter P, Cuvelier C, et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy and osteoartritis: influence of disease duration and activity. Ann Rheum Dis 2000; 59: 945–953.
- 5Cauli A, Yanni G, Panayi GS. Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane. Br J Rheumatol 1997; 36: 935–940.
- 6Alsalameh S, Winter K, Al-Ward R, Wendler J, Kalden JR, Kinne RW. Distribution of TNF-alpha, TNF-R55 and RNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vincinity of TNF receptors in the deeper layers. Scand J Immunol 1999; 49: 278–285.
- 7Katrib A, Tak PP, Bertouch JV, et al. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology 2001; 40: 988–994.
- 8Blom AB, Radstake TR, Holthuysen AE, et al. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum 2003; 48: 1002–1014.
- 9Smeets TJ, Barg EC, Kraan MC, Smith MD, Breedveld FC, Tak PP. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 2003; 62: 635–638.
- 10Yanni G, Whelan A, Freighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 39–44.
- 11Mulherin D, FitzGerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996; 39: 115–124.
- 12Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis: mastermind or workhorse in arthritis? Arthritis Rheum 1997; 40: 5–18.
- 13Barrera P, Blom A, van Lent PL, et al. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum 2000; 43: 1951–1959.
- 14Paleolog E. The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis. Expert Opin Invest Drugs 2003; 12: 1087–1095.
- 15Shanahan JC, St Clair W. Tumor necrosis factor-alpha blockade: a novel therapy for rheuamatic disease. Clin Immunol 2002; 103: 231–242.
- 16Baeten D, De Keyser F. The histopathology of spondyloarthropathy. Curr Mol Med 2004; 4: 1–12.
- 17Baeten D, Kruithof E, Van den Bosch F, et al. Immunomodulatory effect of anti-tumor necrosis factor alpha therapy on synovium in spondyloarthropathy: histologic findings in eight patients from an open-label pilot trial. Arthritis Rheum 2001; 44: 186–195.
- 18Kruithof E, Baeten D, Van den Bosch F, Mielants H, Veys EM, De Keyser F. Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy. Ann Rheum Dis 2004; Sept 23 [Epub ahead of print].
- 19Smeets TJM, Kraan MC, Van Loon ME, Tak PP. Tumor necrosis α blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum 2003; 48: 2155–2162.
- 20Van den Brande JM, Braat H, van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003; 124: 1774–1785.
- 21Odink K, Cerletti N, Brüggen J, et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987; 330: 80–82.
- 22Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004; 344: 37–51.
- 23Teigelkamp S, Bhardwaj RS, Roth J, Meinardus-Hager G, Karas M, Sorg C. Calcium dependent complex assembly of the myeloic differentiation proteins MRP8 and MRP14. J Biol Chem 1991; 266: 13 462–13 467.
- 24Roth J, Burwinkel F, van den Bos C, Goebeler M, Vollmer E, Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993; 82: 1875–1883.
- 25Frosch M, Strey A, Vogl T, et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43: 628–637.
- 26Youssef P, Roth J, Frosch M, et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 1999; 26: 2523–2528.
- 27Kane D, Roth J, Frosch M, Vogl T, Bresnihan B, FitzGerald O. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum 2003; 48: 1676–1685.
- 28Foell D, Frosch M, Schulzezur Wiesch A, Vogl T, Sorg C, Roth J. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis 2004; 63: 206–208.
- 29Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994; 21: 733–738.
- 30Sanchez C, Domenech N, Vazquez J, Alonso F, Ezquerra A, Dominguez J. The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. J Immunol 1999; 162: 5230–5237.
- 31Van den Heuvel MM, Tensen CP, van As JH, et al. Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 1999; 66: 858–866.
- 32Högger P, Dreier J, Froste A, Buck F, Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998; 161: 1883–1890.
- 33Sulahian TH, Högger P, Wahner AE, et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000; 12: 1312–1321.
- 34Fonseca JE, Edwards JC, Blades S, Goulding NJ. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments. Arthritis Rheum 2002; 46: 1210–1216.
- 35Baeten D, Moller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F. Local production of soluble CD163 impairs lymphocyte activation in spondyloarthropathy synovitis. Arthritis Rheum 2004; 50: 1611–1623.
- 36Dougados M, Van der Linden S, Juhlin R, et al. The European spondyloarthropathy study group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991; 34: 1218–1227.
- 37Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.
- 38Baeten D, Van den Bosch F, Elewaut D, Stuer A, Veys EM, De Keyser F. Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin Rheumatol 1999; 18: 434–441.
- 39Smeets TJM, Dolhain RJEM, Breedveld FC, Tak PP. Analysis of the cellular infiltrate and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J Pathol 1998; 186: 75–81.
- 40Rammes A, Roth J, Goebeler M, Klemt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997; 272: 9496–9502.
- 41Roth J, Teigelkamp S, Wilke M, Grun L, Tummler B, Sorg C. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992; 186: 304–314.
- 42Van den Bosch C, Roth J, Koch HG, Hartmann M, Sorg C. Phosphorylation of MRP14, an S100 protein expressed during monocytic differentiation, modulates Ca2 + -dependent translocation from the cytoplasm to membranes and cytoskeleton. J Immunol 1996; 156: 1247–1254.
- 43Kinne RW, Brauer R, Stuhlmuller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2: 189–202.
- 44Baeten D, Demetter P, Cuvelier CA, et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 2002; 196: 343–350.
- 45Vandooren B, Kruithof E, Yu DTY, et al. Matrix metalloproteinases and their inhibitors are involved in peripheral synovitis and down-regulated by TNFα blockade in spondyloarthropathy. Arthritis Rheum 2004; 50: 2942–2953.
- 46Gu J, Rihl M, Marker-Hermann E, et al. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol 2002; 29: 2159–2164.
- 47Baeten D, Boots AM, Steenbakkers PG, et al. Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000; 43: 1233–1243.
- 48Sampson B, Fagerhol MK, Sunderkotter C, et al. Hyperzincaemia and hyperprotectinaemia: a new disorder of zinc metabolism. Lancet 2002; 360: 1742–1745.
- 49Srikrishna G, Panneerselvam K, Westphal V, Abraham V, Varki A, Freeze HH. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 2001; 166: 4678–4688.
- 50Robinson MJ, Tessier P, Poulsom R, Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 2002; 277: 3658–3665.
- 51Newton RA, Hogg, N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 1998; 160: 1427–1435.
- 52Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of pro-inflammatory molecules. Trends Immunol 2003; 24: 155–158.
- 53Hamann W, Floter A, Schmutzler W, Zwadlo-Klarwasser G. Characterisation of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid treated human monocytes. Inflamm Res 1995; 44: 535–540.
- 54Schebesch B, Kodelja V, Muller C, et al. Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 1997; 92: 478–486.
- 55Hogger P, Sorg C. Soluble CD163 inhibits phorbol ester-activated T-lymphocyte proliferation. Biochem Biophys Res Commun 2001; 288: 841–843.
- 56Frings W, Dreiser J, Sorg C. Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Lett 2002; 526: 93–96.